Showing results (1651-1660 of 1,777) with videos related to

Sort By:
Pageof 178
Scientific Reports|December 3, 2017
Screening and identification of lncRNAs as potential biomarkers for pulmonary tuberculosisZhong-Liang Chen, Li-Liang Wei, Li-Ying Shi, et al.
Oncotarget|December 25, 2015
TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathwayShu-Yang Wang, Ke Gao, Dan-Ling Deng, et al.
Journal of Visualized Experiments : Jove|August 13, 2019
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus SubtypesSaahir Khan, Aarti Jain, Omid Taghavian, et al.
Protein and Peptide Letters|June 21, 2019
Applications of Molecular Simulation in the Discovery of Antituberculosis Drugs: A ReviewJian-Ping Hu, Zhi-Xiang Wu, Tao Xie, et al.
BMC Infectious Diseases|September 1, 2025
Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in ChinaHuicong Liu, Liping Zou, JiaJia Yu, et al.
Scientific Reports|October 27, 2015
Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosisChong Wang, Li-Liang Wei, Li-Ying Shi, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 29, 2021
Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRCChengmei Huang, Ruizhang Ou, Xiaoning Chen, et al.
Pharmacological Research|October 28, 2023
Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancerShifen Zhang, Na Li, Feifei Wang, et al.
BMC Medicine|April 12, 2024
PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancerMingzhou Li, Jianbiao Xiao, Shasha Song, et al.
Frontiers in Oncology|May 2, 2022
TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical OutcomesJian Hong, Leiming Xia, Zhenqi Huang, et al.
Pageof 178